343 related articles for article (PubMed ID: 1675587)
1. High-frequency activation of single CD4+ and CD8+ T cells to proliferate and secrete cytokines using anti-receptor antibodies and IL-2(1).
Maraskovsky E; Pech MH; Kelso A
Int Immunol; 1991 Mar; 3(3):255-64. PubMed ID: 1675587
[TBL] [Abstract][Full Text] [Related]
2. Regulation of thymocyte proliferation by alpha beta TcR+ CD3+ CD4- CD8- cloned natural suppressor (NS) cells.
Van Vlasselaer P; Fischer M; Strober S; Zlotnik A
Cell Immunol; 1991 Aug; 136(1):1-15. PubMed ID: 1829396
[TBL] [Abstract][Full Text] [Related]
3. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
Kunicka JE; Platsoucas CD
Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
[TBL] [Abstract][Full Text] [Related]
4. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
5. Bispecific antibody-directed antitumor activity of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus interleukin 2.
Nishimura T; Nakamura Y; Takeuchi Y; Gao XH; Tokuda Y; Okumura K; Habu S
Jpn J Cancer Res; 1991 Nov; 82(11):1207-10. PubMed ID: 1836455
[TBL] [Abstract][Full Text] [Related]
6. Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction.
Kelso A
J Immunol; 1990 Oct; 145(7):2167-76. PubMed ID: 1975827
[TBL] [Abstract][Full Text] [Related]
7. Role of IL-2, IL-4 and IL-6 in the growth and differentiation of tumor-specific CD4+ T helper and CD8+ T cytotoxic cells.
Selvan RS; Nagarkatti PS; Nagarkatti M
Int J Cancer; 1990 Jun; 45(6):1096-104. PubMed ID: 1972141
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD3 antibodies induce T cells from unprimed animals to secrete IL-4 both in vitro and in vivo.
Flamand V; Abramowicz D; Goldman M; Biernaux C; Huez G; Urbain J; Moser M; Leo O
J Immunol; 1990 Apr; 144(8):2875-82. PubMed ID: 1969874
[TBL] [Abstract][Full Text] [Related]
9. CD4-CD8- human T cells: phenotypic heterogeneity and activation requirements of freshly isolated "double-negative" T cells.
Bender A; Kabelitz D
Cell Immunol; 1990 Jul; 128(2):542-54. PubMed ID: 2141552
[TBL] [Abstract][Full Text] [Related]
10. Multiple sub-sets of CD4+ and CD8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles.
Maccalli C; Mortarini R; Parmiani G; Anichini A
Int J Cancer; 1994 Apr; 57(1):56-62. PubMed ID: 7908659
[TBL] [Abstract][Full Text] [Related]
11. Establishment of stable CD8+ suppressor T cell clones and the analysis of their suppressive function.
Hu FY; Asano Y; Sano K; Inoue T; Furutani-Seiki M; Tada T
J Immunol Methods; 1992 Jul; 152(1):123-34. PubMed ID: 1386378
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD8+ thymocytes are susceptible to DNA fragmentation induced by phorbol ester, calcium ionophore and anti-CD3 antibody.
Tadakuma T; Kizaki H; Odaka C; Kubota R; Ishimura Y; Yagita H; Okumura K
Eur J Immunol; 1990 Apr; 20(4):779-84. PubMed ID: 1971792
[TBL] [Abstract][Full Text] [Related]
13. Subpopulations of CD4+ cells in lpr/lpr mice: differences in expression of T cell receptor/CD3 complex and proliferative responses.
Asano T; Yoshikai Y; Matsumoto K; Matuzaki G; Nomoto K
Clin Exp Immunol; 1990 Jul; 81(1):90-6. PubMed ID: 1696186
[TBL] [Abstract][Full Text] [Related]
14. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
Yoshizawa H; Chang AE; Shu SY
Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
[TBL] [Abstract][Full Text] [Related]
15. The role of T-cell subsets in the response to anti-CD3 monoclonal antibodies.
Finck BK; Yung CM; Carteron NL; Wofsy D
Clin Immunol Immunopathol; 1992 Dec; 65(3):234-41. PubMed ID: 1360341
[TBL] [Abstract][Full Text] [Related]
16. Lineage relationships and developmental kinetics of immature thymocytes: CD3, CD4, and CD8 acquisition in vivo and in vitro.
Petrie HT; Hugo P; Scollay R; Shortman K
J Exp Med; 1990 Dec; 172(6):1583-8. PubMed ID: 2147945
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of CD4 and CD8 engagement on the development of cytokine profiles of murine CD4+ and CD8+ T lymphocytes.
Campbell SB; Komata T; Kelso A
Immunology; 2000 Mar; 99(3):394-401. PubMed ID: 10712669
[TBL] [Abstract][Full Text] [Related]
18. Minimal growth requirements of mature T lymphocytes: interleukin (IL)-1 and IL-6 increase growth rate but not plating efficiency of CD4 cells stimulated with anti-CD3 and IL-2.
Soldaini E; MacDonald HR; Nabholz M
Eur J Immunol; 1992 Jul; 22(7):1707-11. PubMed ID: 1352498
[TBL] [Abstract][Full Text] [Related]
19. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
20. Purified human T cells stimulated with cross-linked anti-CD3 monoclonal antibody OKT3: rIL-1 is a co-stimulatory factor for CD4+CD29+CD45RA- T cells.
Panzer S; Geller RL; Bach FH
Scand J Immunol; 1990 Oct; 32(4):359-71. PubMed ID: 1700468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
